Search

Your search keyword '"Begum, Sofina"' showing total 145 results

Search Constraints

Start Over You searched for: Author "Begum, Sofina" Remove constraint Author: "Begum, Sofina"
145 results on '"Begum, Sofina"'

Search Results

1. Urinary eicosanoid levels in early life and risk of atopic disease in childhood

2. Outcomes of single- versus multi-port video-assisted thoracoscopic surgery: Data from a multicenter randomized controlled trial of video-assisted thoracoscopic surgery versus thoracotomy for lung cancer

3. Metabolite signatures associated with microRNA miR-143-3p serve as drivers of poor lung function trajectories in childhood asthma

6. Pharmacometabolomics of Asthma as a Road Map to Precision Medicine

7. A molecular phenomics approach to complex multisystemic diseases

8. Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease

13. Outcomes of single versus multi-port video-assisted thoracoscopic surgery: data from a multi-centre randomised controlled trial of video-assisted thoracoscopic surgery versus thoracotomy for lung cancer

14. 81 Evaluation of neoadjuvant chemo-immunotherapy for operable non-small cell lung cancer: clinical outcomes and impact on service delivery

17. Mirnaome-Metabolome Wide Association Study Reveals Effects of Mirna Regulation in Eosinophilia and Airflow Obstruction in Childhood Asthma

18. Maintaining safe lung cancer surgery during the COVID-19 pandemic in a global city

19. Nucleotide, Phospholipid, and Kynurenine Metabolites Are Robustly Associated with COVID-19 Severity and Time of Plasma Sample Collection in a Prospective Cohort Study

20. Sphingolipid classes and the interrelationship with pediatric asthma and asthma risk factors

21. OMICmAge: An integrative multi-omics approach to quantify biological age with electronic medical records

22. Sphingolipid classes and the interrelationship with pediatric asthma and asthma risk factors.

23. Nucleotide, Phospholipid, and Kynurenine Metabolites Are Robustly Associated with COVID-19 Severity and Time of Plasma Sample Collection in a Prospective Cohort Study.

24. Sphingolipid classes and the interrelationship with pediatric asthma risk factors and clinical asthma phenotypes

25. Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis

26. Prediction of next generation sequencing test failure in lung adenocarcinoma in a genomic laboratory hub setting

27. Utility of Nuclear Grading System in Epithelioid Malignant Pleural Mesothelioma in Biopsy-heavy Setting: An External Validation Study of 563 Cases

28. Body composition and lung cancer-associated cachexia in TRACERx

29. The evolution of non-small cell lung cancer metastases in TRACERx

30. The evolution of lung cancer and impact of subclonal selection in TRACERx

31. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

32. A meta-analysis of immune cell fractions at high resolution reveals novel associations with common phenotypes and health outcomes

35. Dual-energy Computed Tomographic Pulmonary Angiography Accurately Estimates Lobar Perfusion Before Lung Volume Reduction for Severe Emphysema

37. Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome

38. Correction to “Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection”

39. Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses

40. Diffusion and Relaxation Edited Proton NMR Spectroscopy of Plasma Reveals a High-Fidelity Supramolecular Biomarker Signature of SARS-CoV-2 Infection

41. Low Volume in Vitro Diagnostic Proton NMR Spectroscopy of Human Blood Plasma for Lipoprotein and Metabolite Analysis: Application to SARS-CoV-2 Biomarkers

42. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines

43. Riding the Wave: Maintaining Safe Lung Cancer Surgery During the COVID-19 Pandemic in a Global City

44. 1 - Prediction of next generation sequencing test failure in lung adenocarcinoma in a genomic laboratory hub setting

45. Baseline Results of the West London lung cancer screening pilot study – Impact of mobile scanners and dual risk model utilisation

46. Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytical Artifact Minimization with Special Reference to COVID-19/SARS-CoV-2 Samples

47. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection

48. Presence of pleomorphic features but not growth patterns improves prognostic stratification of epithelioid malignant pleural mesothelioma by 2‐tier nuclear grade

49. Utility of Nuclear Grading System in Epithelioid Malignant Pleural Mesothelioma in Biopsy-heavy Setting

Catalog

Books, media, physical & digital resources